The Fund is up 1.9% year-to-date, underperforming its benchmark and peer group due primarily to stock selection. Read more ...

NeueHealth, Inc. reports Q2 2025 profitability with $19M adjusted EBITDA, 45% consumer growth, new partnerships, and the innovative NeuePulse platform.

The major sports shoe manufacturers are feeling the impact of US import duties, with annual costs of around US$1.4 billion ...

Good day, ladies and gentlemen, and welcome to the Ziff Davis Second Quarter 2025 Earnings Conference Call. My name is Tom, and I will be the operator assisting you today. [Operator Instructions] On ...

Richter said, "We are reaffirming the fiscal year 2025 guidance range that we presented in February 2025." The guidance range "has a top end that reflects fiscal year 2025 projected results that imply ...

British American Tobacco (BTI) seems overbought with a 10%+ pullback likely. Valuation concerns and better yield options lead ...

Discover Warner Music Group's strong Q3 2025 performance, with revenue and margin growth, strategic initiatives, market share gains, and a bold outlook ...

Discover Enovis Corporation's Q2 2025 earnings insights: revenue growth, new CEO roadmap, raised guidance, and innovation highlights.

Many of the largest publicly traded US health insurers had a difficult second quarter as rising costs associated with ...

Explore NetScout's Q1 2026 earnings call insights: double-digit cybersecurity growth, AI-driven product innovations, strong financials, and ...

Upgrading Wayfair to 'Buy' after 2Q25 results show clear inflection: revenue growth, margin expansion, and positive cash flow signal scalable profitability. W is gaining undeniable market share, ...

Vogt reiterated 2025 full year revenue guidance of $250 million to $300 million, including sales from Amtagvi in the U.S. and Proleukin globally, and noted, "We continue to see strong demand for ...